(Q42644178)

English

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.

scientific article published on 10 July 2017

Statements

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit